Figure 2.
Clinical and laboratory parameters of COVID‐19 patients before and after TCZ treatment. COVID‐19, coronavirus disease 2019; TCZ, tocilizumab
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.